Our review paper highlights the role of epidermal growth factor receptor (EGFR) and its downstream signaling in seven different kidney pathologies: glomerulonephritis, diabetic nephropathy, hypertensive nephropathy, acute kidney injury, Chronic kidney disease, real transplant, and renal fibrosis. This evidence concerns the gene EGFR and chronic kidney disease.